[Cancer Management and Research](cancer-management-and-research-journal) » [Volume 14](cancer-management-and-research-archive55-v1655)
Feasibility and Safety of Anlotinib Monotherapy for Patients with Previously Treated Advanced Esophageal Squamous Cell Carcinoma: A Real-World Exploratory Study
Authors [Zhang S](author_profile.php?id=1654738) , [Wang X](author_profile.php?id=1209557) , [Gu H](author_profile.php?id=1508935) , [Liu JQ](author_profile.php?id=1045228)
Received 22 January 21 March 2022
Published 13 May 2022 Volume 2022:14 Pages 1715—1727
DOI https://doi.org/10.2147/CMAR.S359482
2
Editor who approved publication: [Dr Sanjeev Srivastava](public_profile.php?id=285660)
Song Zhang, Xin Wang, Hao Gu, Jun-Qi Liu
Department of Radiation …
Feasibility and Safety of Anlotinib Monotherapy for Patients with Previously Treated Advanced Esophageal Squamous Cell Carcinoma: A Real-World Exploratory Study
Rose Duesterwald
Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.
All Posts
